Reports Q4 revenue $4.99B vs. $4.86B a year ago. "We closed the year with a strong fourth quarter and demonstrated operating discipline in a dynamic environment while providing patient-centered high quality care," said CEO Saum Sutaria. "Our momentum going into 2023 positions us for continued growth as we remain focused on expanding our industry-leading ambulatory business and investing in technology, innovation, and talent."
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on THC:
- Tenet options imply 7.4% move in share price post-earnings
- 3 Stocks to Buy Today, 1/27/2023, According to Top Analysts
- Tenet Healthcare CFO Daniel Cancelmi retiring at year-end
- Tenet Healthcare now sees 2022 adjusted EBITDA above $3.425B guidance midpoint
- Greenlight took ‘medium-sized’ Tenet Healthcare position in Q4, Bloomberg says
